To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Directors dealings

Release Date: 05/10/2012 07:06
Code(s): APN     PDF:  
Wrap Text
Directors dealings

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


DEALING IN SECURITIES BY DIRECTORS OF A MAJOR SUBSIDIARY

In compliance with paragraph 3.63 of the Listings Requirements of the
JSE Limited, disclosure is made of the following information:

Director                       :   Gregory Lan
Subsidiary Company             :   Aspen Asia Pacific Pty Limited
Date of transaction            :   3 October 2012
Nature of transaction          :   Acceptance of share appreciation
                                   rights
Number of securities           :   30 239
Class of securities            :   Ordinary shares
Grant price                    :   R142.20
Value of Transaction           :   R 4 300 000.00
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes



Director                       :   Trevor Ziman
Subsidiary Company             :   Aspen Asia Pacific Pty Limited
Date of transaction            :   3 October 2012
Nature of transaction          :   Acceptance of share appreciation
                                   rights
Number of securities           :   30 239
Class of securities            :   Ordinary shares
Grant price                    :   R142.20
Value of Transaction           :   R 4 300 000.00
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes


All acceptances of share appreciation rights are deemed to be off-
market trades.

Durban
5 October 2012

Sponsor
Investec Bank Limited

Date: 05/10/2012 07:06:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story